Latest News – REPRODUCTIVE RIGHTS ALERTS

24 Sep

Republican Senator Cassidy says abortion pill makers turn blind eye to safety

PhoenixLatest NewsAbortion Pill, Anti-abortion, GOP, Trump

Health chairman raises concerns about third-party providers, lax oversight

23 Sep

Green Party plagued by ‘extraordinary misogyny’, member claims

RileyLatest NewsGreenParty, misogyny, UK

Former candidate accuses senior figures in the party of downplaying the ‘hostile’ treatment of female councillors

22 Sep

Three Years In: How Indiana’s Abortion Ban has Weakened its Fragile Health Care System

AlanLatest NewsAbortion Care, Abortion Rights, Healthcare, Indiana, Reproductive rights

The impacts of anti-abortion policies are not limited to those who need to terminate a pregnancy, or even those who become pregnant.

22 Sep

Reproductive Health Care Post-Roe (2025-2026)

RileyLatest NewsAbortion Rights, Healthcare, Post Dobbs, Red States, Reproductive rights, Southern States

Duke University Hospital’s unique geography (North Carolina is the furthest southern state now permitting abortion care), along with its institutional structure (private rather than public), make it an ideal place to examine access to reproductive healthcare. This project documented the medical, ethical and political conditions of the post-Roe landscape as seen from the viewpoints and experiences of reproductive care providers.

21 Sep

2026 Young People’s Reproductive Justice Policy Agenda

RileyLatest Newsgender equality, Healthcare, Reproductive Justice, Reproductive rights

Young people today—a majority of whom are Black, Indigenous, Asian American, Native Hawaiian, Pacific Islander, or Latinx/a—are on the frontlines of the fight for Reproductive Justice: organizing, educating, shifting culture, and building power with URGE. URGE envisions a liberated world where we can live with justice, love freely, express our gender and sexuality, and define and create families of our choosing.

20 Sep

WHO Guidelines on Expanding Contraceptive Options

RileyLatest NewsContraception, Global, Reproductive care, Reproductive rights

WHO, HRP and IBP Network launch new guidelines on expanding contraceptive options for women and girls. The guidelines provide evidence-based recommendations to support greater access to and choice of contraceptive methods, including opportunities to expand how and where existing methods are offered and used, alongside additional contraceptive options.

19 Sep

Reproductive Freedom for All Slams Fifth Circuit Case That Threatens Mifepristone Access Nationwide Ahead of Oral Arguments

MorganLatest NewsAnti-abortion, GOP, Healthcare, Louisiana, Red States, Reproductive rights, United States

The U.S. Court of Appeals for the Fifth Circuit will hear oral arguments in Louisiana v. U.S. Food and Drug Administration (FDA), a lawsuit seeking to end mail and pharmacy access to mifepristone nationwide—including in states where abortion is protected.

18 Sep

Guttmacher Institute Announces 2026–2029 Strategic Plan to Meet Urgent Challenges Facing Sexual and Reproductive Health and Rights

MorganLatest NewsAbortion Care, Abortion Rights, Global., Guttmacher Institute, Healthcare, Reproductive rights

The Guttmacher Institute today announced its 2026–2029 Strategic Plan, a focused roadmap for strengthening the Institute’s role as a trusted source of evidence and action at a time of profound threats to sexual and reproductive health and rights (SRHR) in the United States and around the world.

17 Sep

The Good Woman Is a Dangerous Myth

AlanLatest NewsHealthcare, Trauma, Women's Health

Not every wound announces itself as violence…sometimes it looks like obedience.

17 Sep

Louisiana State asks appeals court to block telehealth access to abortion medications

MorganLatest NewsAbortion Pills, Abortion Rights, Anti-abortion, GOP, Louisiana, Red States

he state of Louisiana wants the 5th U.S. Circuit Court of Appeals to overturn federal policy allowing out-of-state doctors to prescribe and mail mifepristone, a drug used in abortion

16 Sep

For Blind and Low Vision Voters, Barriers Remain

MorganLatest NewsDisabled, Healthcare, United States, Voter Access, Voting

For many blind and low vision voters the right to cast a private and independent ballot remains out of reach despite decades of legal protections. While technology has improved, the implementation remains imbalanced, resulting in blind and low vision voters having to give up their privacy, independence, or both.

15 Sep

US states’ lawsuit seeking to curb abortion drug access paused for now

DevonLatest NewsAbortion Pills, Anti-Abortion GOP, Healthcare, Reproductive rights, Trump, United States

A federal judge paused a lawsuit by Florida and Texas seeking to severely limit access to the abortion pill mifepristone nationwide while ‌President Donald Trump's administration completes a review of the drug's safety.

14 Sep

Reproductive Justice Maryland Action is currently evaluating candidates for endorsement in the 2026 election cycle.

DevonLatest NewsDemocratic, Maryland, Reproductive Justice, Reproductive rights, United States, Vote

Maryland Endorsed Candidates

13 Sep

Collins’s Kavanaugh vote becomes key weapon for opponents

DevonLatest NewsAbortion Rights, Anti-abortion, GOP, Healthcare, Maine, Reproductive rights, SusanCollins, Trump, United States, Vote

Democrats and reproductive rights groups are zeroing in on Sen. Susan Collins’s (R-Maine) vote to confirm Justice Brett Kavanaugh as a pillar of their campaign to oust her, arguing she paved the way for the Supreme Court’s decision to overturn Roe v. Wade.

12 Sep

Virginia District Court Rules FDA Unlawfully Restricted Abortion Pill Access

ChaseLatest NewsAbortion Pills, Abortion Rights, Healthcare, Reproductive rights, Telehealth, United States

A Virginia district court judge ordered the FDA to reconsider its restrictions on mifepristone, a highly safe and effective prescription medication for terminating early pregnancy. The judge, Robert S. Ballou, sided with reproductive health clinics in three states that argued that current restrictions are excessive, medically unnecessary, and inconsistent with federal law. The challenged restrictions are part of FDA’s 2023 risk evaluation mitigation strategy (2023 REMS).